These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11328199)

  • 1. Visual impairment in anti-GQ1b positive Miller Fisher syndrome.
    Colding-Jørgensen E; Vissing J
    Acta Neurol Scand; 2001 Apr; 103(4):259-60. PubMed ID: 11328199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optic neuritis in a patient with Miller-Fisher syndrome.
    Lolekha P; Phanthumchinda K
    J Med Assoc Thai; 2008 Dec; 91(12):1909-13. PubMed ID: 19133529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miller Fisher syndrome: toward a more comprehensive understanding.
    Li H; Yuan J
    Chin Med J (Engl); 2001 Mar; 114(3):235-9. PubMed ID: 11780304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunological spectrum of the Miller Fisher syndrome.
    Lo YL
    Muscle Nerve; 2007 Nov; 36(5):615-27. PubMed ID: 17657801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electrophysiologic study of 10 cases of Miller Fisher syndrome].
    Durand MC; Goulon-Goéau C; Schweitzer A; Chéliout-Héraut F; Raphael JC; Gajdos P
    Rev Neurol (Paris); 2001 Jan; 157(1):72-9. PubMed ID: 11240551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Fisher variant of Guillain-Barré syndrome (Fisher syndrome).
    Snyder LA; Rismondo V; Miller NR
    J Neuroophthalmol; 2009 Dec; 29(4):312-24. PubMed ID: 19952907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miller Fisher syndrome: axonal, demyelinating or both?
    Scelsa SN; Herskovitz S
    Electromyogr Clin Neurophysiol; 2000 Dec; 40(8):497-502. PubMed ID: 11155543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of Miller Fisher syndrome with anti GQ1b in Thailand.
    Sawanyawisuth K; Tiamkao S; Jitpimolmard S; Vincent A
    J Med Assoc Thai; 2007 Feb; 90(2):391-3. PubMed ID: 17375649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Unilateral optic neuritis and Miller Fisher syndrome].
    Tabary A; Lousteau B; Signolles C
    J Fr Ophtalmol; 2013 Jun; 36(6):e93-9. PubMed ID: 23688610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
    Prendergast MM; Moran AP
    J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible conduction failure in overlap of Miller Fisher syndrome and pharyngeal-cervical-brachial variant of Guillain-Barré syndrome in the spectrum of nodo-paranodopathies.
    Gürsoy AE; Kolukısa M; Babacan-Yıldız G; Altıntaş Ö; Yaman A; Asil T
    J Clin Neurosci; 2014 Jul; 21(7):1269-71. PubMed ID: 24534627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-GQ1b ganglioside antibody in peripheral nervous system disorders: pathophysiologic role and clinical relevance.
    Paparounas K
    Arch Neurol; 2004 Jul; 61(7):1013-6. PubMed ID: 15262730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding.
    Jacobs BC; O'Hanlon GM; Bullens RW; Veitch J; Plomp JJ; Willison HJ
    Brain; 2003 Oct; 126(Pt 10):2220-34. PubMed ID: 12876146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrent Miller-Fisher syndrome].
    Battaglia F; Attane F; Robinson A; Martini L; Siboni J; Tannier C
    Rev Neurol (Paris); 2005 Sep; 161(8-9):844-7. PubMed ID: 16244569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Miller-Fisher syndrome].
    Jørgensen L; Vedeler CA
    Tidsskr Nor Laegeforen; 2005 May; 125(10):1327-8. PubMed ID: 15909003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular junction dysfunction in Miller Fisher syndrome.
    Silverstein MP; Zimnowodzki S; Rucker JC
    Semin Ophthalmol; 2008; 23(3):211-3. PubMed ID: 18432547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Miller Fisher syndrome: review of the literature and presentation of 2 cases].
    Scoppetta C; Fontana M; Quadrini R; La Cesa I; Di Lello R; Peppe A; Tolli VS; Casali C
    Riv Neurol; 1991; 61(4):137-44. PubMed ID: 1667714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral internal ophthalmoplegia as an initial sole manifestation of Miller Fisher syndrome.
    Bae JS; Kim JK; Kim SH; Kim OK
    J Clin Neurosci; 2009 Jul; 16(7):963-4. PubMed ID: 19339185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.